Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party†
出版年份 2018 全文链接
标题
Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party†
作者
关键词
-
出版物
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 73, Issue suppl_3, Pages iii2-iii78
出版商
Oxford University Press (OUP)
发表日期
2018-02-21
DOI
10.1093/jac/dky027
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Recent advances in biochemical and molecular diagnostics for the rapid detection of antibiotic-resistant Enterobacteriaceae: a focus on ß-lactam resistance
- (2017) Jean-Winoc Decousser et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Might real-time pharmacokinetic/pharmacodynamic optimisation of high-dose continuous-infusion meropenem improve clinical cure in infections caused by KPC-producing Klebsiella pneumoniae?
- (2017) Federico Pea et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Evaluation of two automated systems for colistin susceptibility testing of carbapenem-resistant Acinetobacter baumannii clinical isolates
- (2017) Sophia Vourli et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotype
- (2017) Edward R. Bevan et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Application of next generation sequencing in clinical microbiology and infection prevention
- (2017) Ruud H. Deurenberg et al. JOURNAL OF BIOTECHNOLOGY
- Colistin and Polymyxin B Susceptibility Testing for Carbapenem-Resistant and mcr -Positive Enterobacteriaceae: Comparison of Sensititre, MicroScan, Vitek 2, and Etest with Broth Microdilution
- (2017) Ka Lip Chew et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Susceptibility Testing for the Polymyxins: Two Steps Back, Three Steps Forward?
- (2017) Shawn Vasoo JOURNAL OF CLINICAL MICROBIOLOGY
- Epidemiology of Escherichia coli bacteraemia in England: results of an enhanced sentinel surveillance programme
- (2017) J. Abernethy et al. JOURNAL OF HOSPITAL INFECTION
- Nanotheranostic approaches for management of bloodstream bacterial infections
- (2017) Pramod Jagtap et al. Nanomedicine-Nanotechnology Biology and Medicine
- Adults miscoded and misdiagnosed as having pneumonia: results from the British Thoracic Society pneumonia audit
- (2017) Priya Daniel et al. THORAX
- Comprehensive resistome analysis reveals the prevalence of NDM and MCR-1 in Chinese poultry production
- (2017) Yang Wang et al. Nature Microbiology
- The Potential Trajectory of Carbapenem-ResistantEnterobacteriaceae, an Emerging Threat to Health-Care Facilities, and the Impact of the Centers for Disease Control and Prevention Toolkit
- (2016) Bruce Y. Lee et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis. A Meta-analysis of Individual Patient Data from Randomized Trials
- (2016) Jason A. Roberts et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae
- (2016) Belén Gutiérrez-Gutiérrez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics and Safety of Ceftolozane-Tazobactam in Adult Cystic Fibrosis Patients Admitted with Acute Pulmonary Exacerbation
- (2016) Marguerite L. Monogue et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program
- (2016) Florian M. Wagenlehner et al. CLINICAL INFECTIOUS DISEASES
- Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program
- (2016) John E. Mazuski et al. CLINICAL INFECTIOUS DISEASES
- Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections: Table 1.
- (2016) Ryan K. Shields et al. CLINICAL INFECTIOUS DISEASES
- Fecal Colonization With Extended-spectrum Beta-lactamase–ProducingEnterobacteriaceaeand Risk Factors Among Healthy Individuals: A Systematic Review and Metaanalysis
- (2016) Styliani Karanika et al. CLINICAL INFECTIOUS DISEASES
- Gram-negative bacteraemia; a multi-centre prospective evaluation of empiric antibiotic therapy and outcome in English acute hospitals
- (2016) J.M. Fitzpatrick et al. CLINICAL MICROBIOLOGY AND INFECTION
- Comparison of the microbiological characteristics and virulence factors of ST131 and non-ST131 clones among extended-spectrum β-lactamase–producing Escherichia coli causing bacteremia
- (2016) Min Kyeong Cha et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Ceftolozane/Tazobactam: A Review in Complicated Intra-Abdominal and Urinary Tract Infections
- (2016) Lesley J. Scott DRUGS
- Identification of a novel plasmid-mediated colistin-resistance gene,mcr-2, inEscherichia coli, Belgium, June 2016
- (2016) Basil Britto Xavier et al. Eurosurveillance
- Plasmid-mediated colistin resistance (mcr-1gene): three months later, the story unfolds
- (2016) Robert L. Skov et al. Eurosurveillance
- Descriptive epidemiology ofEscherichia colibacteraemia in England, April 2012 to March 2014
- (2016) Sabine Bou-Antoun et al. Eurosurveillance
- The differential importance of mutations within AmpD in cephalosporin resistance of Enterobacter aerogenes and Enterobacter cloacae
- (2016) Baharak Babouee Flury et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Extraintestinal pathogenic Escherichia coli sequence type 131 H30-R and H30-Rx subclones in retail chicken meat, Italy
- (2016) Arash Ghodousi et al. INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
- Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis
- (2016) Oren Zusman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of temocillin in a lethal murine model of infection of intra-abdominal origin due to KPC-producingEscherichia coli
- (2016) K. Alexandre et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Amikacin use and therapeutic drug monitoring in adults: do dose regimens and drug exposures affect either outcome or adverse events? A systematic review
- (2016) Abi Jenkins et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- CTX-M-15-H30Rx-ST131 subclone is one of the main causes of healthcare-associated ESBL-producingEscherichia colibacteraemia of urinary origin in Spain
- (2016) Irene Merino et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Population structure ofEscherichia colicausing bacteraemia in the UK and Ireland between 2001 and 2010
- (2016) M. J. Day et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study
- (2016) Belén Gutiérrez-Gutiérrez et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Role of cephalosporins in the era ofClostridium difficileinfection
- (2016) Mark H. Wilcox et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Prevention and control of multi-drug-resistant Gram-negative bacteria: recommendations from a Joint Working Party
- (2016) A.P.R. Wilson et al. JOURNAL OF HOSPITAL INFECTION
- Plasmid-mediated colistin resistance mechanisms: is it time to revise our approach to selective digestive decontamination?
- (2016) Timothy Miles Rawson et al. LANCET INFECTIOUS DISEASES
- Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study
- (2016) Yehuda Carmeli et al. LANCET INFECTIOUS DISEASES
- Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study
- (2016) Yi-Yun Liu et al. LANCET INFECTIOUS DISEASES
- The Best Use of the Charlson Comorbidity Index With Electronic Health Care Database to Predict Mortality
- (2016) Aurélie Bannay et al. MEDICAL CARE
- In VitroActivity of Ceftolozane Alone and in Combination with Tazobactam against Extended-Spectrum-β-Lactamase-Harboring Enterobacteriaceae
- (2015) Maria J. B. Melchers et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Case-Control Study of the Risk Factors for Acquisition of Pseudomonas and Proteus Species during Tigecycline Therapy
- (2015) Ga Eun Park et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Plasmid-Mediated OqxAB Is an Important Mechanism for Nitrofurantoin Resistance in Escherichia coli
- (2015) Pak-Leung Ho et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cefepime Therapy for Monomicrobial Enterobacter cloacae Bacteremia: Unfavorable Outcomes in Patients Infected by Cefepime-Susceptible Dose-Dependent Isolates
- (2015) Nan-Yao Lee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Amdinocillin (Mecillinam) Resistance Mutations in Clinical Isolates and Laboratory-Selected Mutants of Escherichia coli
- (2015) Elisabeth Thulin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of Imipenem with Relebactam against Gram-Negative Pathogens from New York City
- (2015) Amabel Lapuebla et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftazidime-Avibactam Activity Tested against Enterobacteriaceae Isolates from U.S. Hospitals (2011 to 2013) and Characterization of β-Lactamase-Producing Strains
- (2015) Mariana Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftazidime-Avibactam Activity against Multidrug-Resistant Pseudomonas aeruginosa Isolated in U.S. Medical Centers in 2012 and 2013
- (2015) Helio S. Sader et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effects of Klebsiella pneumoniae Carbapenemase Subtypes, Extended-Spectrum β-Lactamases, and Porin Mutations on theIn VitroActivity of Ceftazidime-Avibactam against Carbapenem-Resistant K. pneumoniae
- (2015) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of Meropenem Combined with RPX7009, a Novel β-Lactamase Inhibitor, against Gram-Negative Clinical Isolates in New York City
- (2015) Amabel Lapuebla et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroSelection of Ceftazidime-Avibactam Resistance in Enterobacteriaceae with KPC-3 Carbapenemase
- (2015) David M. Livermore et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of polymyxin susceptibility profile among KPC-producingKlebsiella pneumoniaeusing Etest and MicroScan WalkAway automated system
- (2015) Leandro Reus Rodrigues Perez APMIS
- Efficacy of polymyxins in the treatment of carbapenem-resistant Enterobacteriaceae infections: a systematic review and meta-analysis
- (2015) Wentao Ni et al. Brazilian Journal of Infectious Diseases
- Updated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform?
- (2015) Roger L. Nation et al. CLINICAL INFECTIOUS DISEASES
- IntermingledKlebsiella pneumoniaePopulations Between Retail Meats and Human Urinary Tract Infections
- (2015) Gregg S. Davis et al. CLINICAL INFECTIOUS DISEASES
- Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI)
- (2015) Joseph Solomkin et al. CLINICAL INFECTIOUS DISEASES
- Thirty day all-cause mortality in patients with Escherichia coli bacteraemia in England
- (2015) J.K. Abernethy et al. CLINICAL MICROBIOLOGY AND INFECTION
- Contemporary resistance trends and mechanisms for the old antibiotics colistin, temocillin, fosfomycin, mecillinam and nitrofurantoin
- (2015) C.G. Giske CLINICAL MICROBIOLOGY AND INFECTION
- Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case–control–control study
- (2015) D.R. Giacobbe et al. CLINICAL MICROBIOLOGY AND INFECTION
- CTX-M-15-non-ST131 Escherichia coli isolates are mainly responsible of faecal carriage with ESBL-producing Enterobacteriaceae in travellers, immigrants and those visiting friends and relatives
- (2015) A. Valverde et al. CLINICAL MICROBIOLOGY AND INFECTION
- Pharmacokinetics and Pharmacodynamics of Continuous Infusion Meropenem in Overweight, Obese, and Morbidly Obese Patients with Stable and Unstable Kidney Function: A Step Toward Dose Optimization for the Treatment of Severe Gram-Negative Bacterial Infections
- (2015) Manjunath P. Pai et al. CLINICAL PHARMACOKINETICS
- Antibiotic-Induced Within-Host Resistance Development of Gram-Negative Bacteria in Patients Receiving Selective Decontamination or Standard Care
- (2015) Yvonne Noteboom et al. CRITICAL CARE MEDICINE
- Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single β-lactamases
- (2015) Krisztina M. Papp-Wallace et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Microbiological activity of ceftolozane/tazobactam, ceftazidime, meropenem, and piperacillin/tazobactam against Pseudomonas aeruginosa isolated from children with cystic fibrosis
- (2015) Joseph L. Kuti et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Activity of temocillin, mecillinam, ceftazidime, and ceftazidime/avibactam against carbapenem-non-susceptible Enterobacteriaceae without carbapenemase production
- (2015) N. T. Mutters et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- The safety of polymyxin antibiotics
- (2015) Theodoros Kelesidis et al. Expert Opinion On Drug Safety
- Dissemination of a clone carrying a fosA3-harbouring plasmid mediates high fosfomycin resistance rate of KPC-producing Klebsiella pneumoniae in China
- (2015) Yan Jiang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Tetracyclines for multidrug-resistant Acinetobacter baumannii infections
- (2015) Matthew E. Falagas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Efficacy and safety of tigecycline for the treatment of severe infectious diseases: an updated meta-analysis of RCTs
- (2015) Fengcai Shen et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Infections caused by KPC-producingKlebsiella pneumoniae: differences in therapy and mortality in a multicentre study—authors' response
- (2015) Mario Tumbarello et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Avibactam confers susceptibility to a large proportion of ceftazidime-resistantPseudomonas aeruginosaisolates recovered from cystic fibrosis patients
- (2015) Hussein Chalhoub et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Sequencing of plasmids pAMBL1 and pAMBL2 fromPseudomonas aeruginosareveals ablaVIM-1amplification causing high-level carbapenem resistance
- (2015) Alvaro San Millan et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials
- (2015) Angela Huttner et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Multidrug-resistant Gram-negative bacteria: a product of globalization
- (2015) P.M. Hawkey JOURNAL OF HOSPITAL INFECTION
- Characterization of the extra-intestinal pathogenic Escherichia coli ST131 clone among isolates recovered from urinary and bloodstream infections in the United Kingdom
- (2015) H. Ciesielczuk et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI)
- (2015) Florian M Wagenlehner et al. LANCET
- Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus
- (2015) Roger L Nation et al. LANCET INFECTIOUS DISEASES
- Carbapenemase-Producing Enterobacteriaceae
- (2015) David Paterson et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Mequindox resistance and in vitro efficacy in animal-derived Escherichia coli strains
- (2015) Tao He et al. VETERINARY MICROBIOLOGY
- Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options
- (2015) Ya-Ting Chang et al. Frontiers in Microbiology
- Cefoxitin as a carbapenem-sparing antibiotic for infections caused by extended-spectrum beta-lactamase-producingEscherichia coliandKlebsiella pneumoniae
- (2015) Solen Kernéis et al. Infectious Diseases
- Gentamicin ototoxicity: a 23-year selected case series of 103 patients
- (2015) Rebekah M Ahmed et al. MEDICAL JOURNAL OF AUSTRALIA
- Antimicrobial Susceptibility and Molecular Mechanisms of Fosfomycin Resistance in Clinical Escherichia coli Isolates in Mainland China
- (2015) Ya Li et al. PLoS One
- Carbapenemase-Producing Klebsiella pneumoniae in Romania: A Six-Month Survey
- (2015) Brandusa Elena Lixandru et al. PLoS One
- Activity of Eravacycline against Enterobacteriaceae and Acinetobacter baumannii, Including Multidrug-Resistant Isolates, from New York City
- (2014) Marie Abdallah et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Post-β-Lactamase-Inhibitor Effect of Tazobactam in Combination with Ceftolozane on Extended-Spectrum-β-Lactamase-Producing Strains
- (2014) Helio S. Sader et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Selective Digestive Tract Decontamination and Spread of Colistin Resistance: Antibiotic Prophylaxis Is Not a Substitute for Hygiene
- (2014) Wolfgang A. Krueger et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacological Study of Cefoxitin as an Alternative Antibiotic Therapy to Carbapenems in Treatment of Urinary Tract Infections Due to Extended-Spectrum-β-Lactamase-Producing Escherichia coli
- (2014) H. Guet-Revillet et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Within-Population Distribution of Trimethoprim Resistance in Escherichia coli before and after a Community-Wide Intervention on Trimethoprim Use
- (2014) Martin Sundqvist et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenem-Resistant Klebsiella pneumoniae Strains Exhibit Diversity in Aminoglycoside-Modifying Enzymes, Which Exert Differing Effects on Plazomicin and Other Agents
- (2014) Reem Almaghrabi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Plazomicin against 5,015 Gram-Negative and Gram-Positive Clinical Isolates Obtained from Patients in Canadian Hospitals as Part of the CANWARD Study, 2011-2012
- (2014) A. Walkty et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Community-Onset Escherichia coli Infection Resistant to Expanded-Spectrum Cephalosporins in Low-Prevalence Countries
- (2014) Benjamin A. Rogers et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems
- (2014) George L. Daikos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activities of Ceftazidime and Avibactam against β-Lactamase-Producing Enterobacteriaceae in a Hollow-Fiber Pharmacodynamic Model
- (2014) Ken Coleman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment of Multidrug-Resistant Gram-Negative Infections in Children
- (2014) A. J. Hsu et al. CLINICAL INFECTIOUS DISEASES
- Surveillance Cultures Growing Carbapenem-Resistant Acinetobacter baumannii Predict the Development of Clinical Infections: A Retrospective Cohort Study
- (2014) R. Latibeaudiere et al. CLINICAL INFECTIOUS DISEASES
- Treating infections caused by carbapenemase-producing Enterobacteriaceae
- (2014) L.S. Tzouvelekis et al. CLINICAL MICROBIOLOGY AND INFECTION
- Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study
- (2014) M. Giannella et al. CLINICAL MICROBIOLOGY AND INFECTION
- Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae is common 12 months after infection and is related to strain factors
- (2014) E. Titelman et al. CLINICAL MICROBIOLOGY AND INFECTION
- Carbapenems and piperacillin/tazobactam for the treatment of bacteremia caused by extended-spectrum β-lactamase–producing Proteus mirabilis
- (2014) Hsih-Yeh Tsai et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Comparison of colistin–carbapenem, colistin–sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections
- (2014) A. Batirel et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Clinical and microbiological impact of discontinuation of fluoroquinolone prophylaxis in patients with prolonged profound neutropenia
- (2014) Anke Verlinden et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Antimicrobial Stewardship Programs in Inpatient Hospital Settings: A Systematic Review
- (2014) Brittin Wagner et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Extended-spectrum cephalosporins and the inoculum effect in tests with CTX-M-type extended-spectrum β-lactamase-producing Escherichia coli: Potential clinical implications of the revised CLSI interpretive criteria
- (2014) Cheol-In Kang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro activity of mecillinam against Enterobacteriaceae with NDM-1 carbapenemase
- (2014) E. C. L. Marrs et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Monotherapy versus combination therapy for sepsis due to multidrug-resistant Acinetobacter baumannii: analysis of a multicentre prospective cohort
- (2014) L. E. Lopez-Cortes et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Waste water effluent contributes to the dissemination of CTX-M-15 in the natural environment
- (2014) G. C. A. Amos et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The efficacy of non-carbapenem antibiotics for the treatment of community-onset acute pyelonephritis due to extended-spectrum -lactamase-producing Escherichia coli
- (2014) S. H. Park et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Combination therapy for carbapenem-resistant Gram-negative bacteria
- (2014) M. Paul et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Temocillin (6 g daily) in critically ill patients: continuous infusion versus three times daily administration
- (2014) P.-F. Laterre et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- NDM carbapenemases in the United Kingdom: an analysis of the first 250 cases
- (2014) A. Jain et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infections
- (2014) A. Oliva et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Gentamicin therapy for sepsis due to carbapenem-resistant and colistin-resistant Klebsiella pneumoniae
- (2014) M. Gonzalez-Padilla et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Ceftazidime/avibactam activity tested against Gram-negative bacteria isolated from bloodstream, pneumonia, intra-abdominal and urinary tract infections in US medical centres (2012)
- (2014) R. K. Flamm et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Risk factors for tracheobronchial acquisition of resistant Gram-negative bacterial pathogens in mechanically ventilated ICU patients
- (2014) Ilias Papakonstantinou et al. JOURNAL OF CHEMOTHERAPY
- Fosfomycin Susceptibility in Carbapenem-Resistant Enterobacteriaceae from Germany
- (2014) M. Kaase et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Ceftolozane/tazobactam activity tested against aerobic Gram-negative organisms isolated from intra-abdominal and urinary tract infections in European and United States hospitals (2012)
- (2014) Helio S. Sader et al. JOURNAL OF INFECTION
- Comparison of Comorbidity Collection Methods
- (2014) Dorina Kallogjeri et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Risk of AKI with Gentamicin as Surgical Prophylaxis
- (2014) S. Bell et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- High Rate of Per Oral Mecillinam Treatment Failure in Community-Acquired Urinary Tract Infections Caused by ESBL-Producing Escherichia coli
- (2014) Arne Søraas et al. PLoS One
- Global dissemination of a multidrug resistant Escherichia coli clone
- (2014) N. K. Petty et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Escherichia coli isolates from sick chickens in China: Changes in antimicrobial resistance between 1993 and 2013
- (2014) Xiang Chen et al. VETERINARY JOURNAL
- Nitrofurantoin Contraindication in Patients with a Creatinine Clearance Below 60 mL/min: Looking for the Evidence
- (2013) Mandy Oplinger et al. ANNALS OF PHARMACOTHERAPY
- In VivoEmergence of Colistin Resistance in Klebsiella pneumoniae Producing KPC-Type Carbapenemases Mediated by Insertional Inactivation of the PhoQ/PhoPmgrBRegulator
- (2013) Antonio Cannatelli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of the MIC of Piperacillin-Tazobactam on the Outcome of Patients with Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Escherichia coli
- (2013) Pilar Retamar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Complete Sequence of pOZ176, a 500-Kilobase IncP-2 Plasmid Encoding IMP-9-Mediated Carbapenem Resistance, from Outbreak Isolate Pseudomonas aeruginosa 96
- (2013) Jianhui Xiong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phase 2, Randomized, Double-Blind Study of the Efficacy and Safety of Two Dose Regimens of Eravacycline versus Ertapenem for Adult Community-Acquired Complicated Intra-Abdominal Infections
- (2013) Joseph S. Solomkin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroInteraction between Cefepime and Amoxicillin-Clavulanate against Extended-Spectrum β-Lactamase-Producing Escherichia coli
- (2013) Edouard Bingen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Successful Ertapenem-Doripenem Combination Treatment of Bacteremic Ventilator-Associated Pneumonia Due to Colistin-Resistant KPC-Producing Klebsiella pneumoniae
- (2013) Giancarlo Ceccarelli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivities of Ceftazidime-Avibactam and Aztreonam-Avibactam against 372 Gram-Negative Bacilli Collected in 2011 and 2012 from 11 Teaching Hospitals in China
- (2013) Xiaojuan Wang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Activity of Ceftolozane-Tazobactam Tested against Enterobacteriaceae and Pseudomonas aeruginosa with Various Resistance Patterns Isolated in U.S. Hospitals (2011-2012)
- (2013) David J. Farrell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nested Case-Control Study of the Emergence of Tigecycline Resistance in Multidrug-Resistant Klebsiella pneumoniae
- (2013) Masayuki Nigo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emergence of Colistin Resistance in Enterobacteriaceae after the Introduction of Selective Digestive Tract Decontamination in an Intensive Care Unit
- (2013) Teysir Halaby et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Relationship between Ceftolozane-Tazobactam Exposure and Drug Resistance Amplification in a Hollow-Fiber Infection Model
- (2013) Brian VanScoy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Epidemiology and Risk Factors for Isolation of Escherichia coli Producing CTX-M-Type Extended-Spectrum β-Lactamase in a Large U.S. Medical Center
- (2013) Kayoko Hayakawa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Humanized Carbapenem and Ceftazidime Regimens against Enterobacteriaceae Producing OXA-48 Carbapenemase in a Murine Infection Model
- (2013) Dora E. Wiskirchen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibiotic Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae: Systematic Evaluation of the Available Evidence
- (2013) Matthew E. Falagas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, against Hospital and Community Pathogens
- (2013) J. A. Sutcliffe et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Organisms Collected from U.S. Medical Centers in 2012
- (2013) Helio S. Sader et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Ertapenem use with Impact Assessment on Extended-Spectrum Beta-Lactamases (ESBL) Production and Gram-Negative resistance in Singapore General Hospital (SGH)
- (2013) Cheryl Li-Ling Lim et al. BMC INFECTIOUS DISEASES
- Effect of Adequate Single-Drug vs Combination Antimicrobial Therapy on Mortality in Pseudomonas aeruginosa Bloodstream Infections: A Post Hoc Analysis of a Prospective Cohort
- (2013) Carmen Peña et al. CLINICAL INFECTIOUS DISEASES
- An Ongoing National Intervention to Contain the Spread of Carbapenem-Resistant Enterobacteriaceae
- (2013) M. J. Schwaber et al. CLINICAL INFECTIOUS DISEASES
- Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial
- (2013) Emanuele Durante-Mangoni et al. CLINICAL INFECTIOUS DISEASES
- Escherichia coli Sequence Type 131 (ST131) Subclone H30 as an Emergent Multidrug-Resistant Pathogen Among US Veterans
- (2013) Aylin Colpan et al. CLINICAL INFECTIOUS DISEASES
- Non-phenotypic tests to detect and characterize antibiotic resistance mechanisms in Enterobacteriaceae
- (2013) Agnese Lupo et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Surveillance of antibiotic susceptibility of Enterobacteriaceae isolated from urine samples collected from community patients in a large metropolitan area, 2010–2012
- (2013) C. S. HORNER et al. EPIDEMIOLOGY AND INFECTION
- Ineffectiveness and adverse events of nitrofurantoin in women with urinary tract infection and renal impairment in primary care
- (2013) Arjen F. J. Geerts et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013
- (2013) C Glasner et al. Eurosurveillance
- Asymptomatic bacteriuria: prevalence rates of causal microorganisms, etiology of infection in different patient populations, and recent advances in molecular detection
- (2013) Deepak S. Ipe et al. FEMS MICROBIOLOGY LETTERS
- Comparison of colistin and colistin/sulbactam for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia
- (2013) G. Kalin et al. INFECTION
- Utility of a Clinical Risk Factor Scoring Model in Predicting Infection with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae on Hospital Admission
- (2013) Steven W. Johnson et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- β-Lactam plus aminoglycoside or fluoroquinolone combination versus β-lactam monotherapy for Pseudomonas aeruginosa infections: A meta-analysis
- (2013) Konstantinos Z. Vardakas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Early (2008–2010) hospital outbreak of Klebsiella pneumoniae producing OXA-48 carbapenemase in the UK
- (2013) Claire P. Thomas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- What is the relevance of fosfomycin pharmacokinetics in the treatment of serious infections in critically ill patients? A systematic review
- (2013) Suzanne Parker et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Activity of fosfomycin alone or combined with cefoxitin in vitro and in vivo in a murine model of urinary tract infection due to Escherichia coli harbouring CTX-M-15-type extended-spectrum β-lactamase
- (2013) Agnès Lefort et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria
- (2013) Konstantinos Pontikis et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Efficacy of tigecycline for the treatment of complicated intra-abdominal infections in real-life clinical practice from five European observational studies
- (2013) C. Eckmann et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emerging clinical role of pivmecillinam in the treatment of urinary tract infection in the context of multidrug-resistant bacteria
- (2013) S. Dewar et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Determining a clinical framework for use of cefepime and -lactam/ -lactamase inhibitors in the treatment of infections caused by extended-spectrum- -lactamase-producing Enterobacteriaceae
- (2013) H. M. Nguyen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections
- (2013) F. Jansaker et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa
- (2013) Damien Fournier et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- High genetic diversity of nitrofurantoin- or mecillinam-resistant Escherichia coli indicates low propensity for clonal spread
- (2013) Hanna O. Poulsen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Travel-associated faecal colonization with ESBL-producing Enterobacteriaceae: incidence and risk factors
- (2013) Åse Östholm-Balkhed et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comparative in vitro activity of sulfametrole/trimethoprim and sulfamethoxazole/trimethoprim and other agents against multiresistant Gram-negative bacteria
- (2013) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro activity of temocillin against multidrug-resistant clinical isolates of Escherichia coli, Klebsiella spp. and Enterobacter spp., and evaluation of high-level temocillin resistance as a diagnostic marker for OXA-48 carbapenemase
- (2013) N. Woodford et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Resistance mechanisms and epidemiology of multiresistant pathogens in Europe and efficacy of tigecycline in observational studies
- (2013) W. R. Heizmann et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Molecular epidemiology of extended-spectrum -lactamase-, AmpC -lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11
- (2013) A. J. Denisuik et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, Phase II trial
- (2013) Christopher Lucasti et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Escherichia coli bacteraemia: 2 years of prospective regional surveillance (2010-12)
- (2013) C. Horner et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Impact of ertapenem use on Pseudomonas aeruginosa and Acinetobacter baumannii imipenem susceptibility rates: collateral damage or positive effect on hospital ecology?
- (2013) D. Sousa et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic model
- (2013) T. Tangden et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change?
- (2013) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Detection, treatment, and prevention of carbapenemase-producingEnterobacteriaceae: Recommendations from an International Working Group
- (2013) Gabriel Levy Hara et al. JOURNAL OF CHEMOTHERAPY
- Predictive Diagnostics for Escherichia coli Infections Based on the Clonal Association of Antimicrobial Resistance and Clinical Outcome
- (2013) V. Tchesnokova et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Abrupt Emergence of a Single Dominant Multidrug-Resistant Strain of Escherichia coli
- (2013) James R. Johnson et al. JOURNAL OF INFECTIOUS DISEASES
- Prevalence and molecular epidemiology of plasmid-mediated fosfomycin resistance genes among blood and urinary Escherichia coli isolates
- (2013) P.-L. Ho et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Urinary Tract Infections Caused by Community-Acquired Extended-Spectrum β-Lactamase-Producing and Nonproducing Bacteria: A Comparative Study
- (2013) Noam Dayan et al. JOURNAL OF PEDIATRICS
- Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: a longitudinal epidemiological and clinical study
- (2013) Mikhail V Edelstein et al. LANCET INFECTIOUS DISEASES
- The role of the natural environment in the emergence of antibiotic resistance in Gram-negative bacteria
- (2013) Elizabeth MH Wellington et al. LANCET INFECTIOUS DISEASES
- Recovery of Multidrug-Resistant Bacteria From Combat Personnel Evacuated From Iraq and Afghanistan at a Single Military Treatment Facility
- (2013) Clinton K. Murray et al. MILITARY MEDICINE
- Long-term resistance trends of uropathogens and association with antimicrobial prophylaxis
- (2013) Maria Bitsori et al. PEDIATRIC NEPHROLOGY
- Risk Factors for Community-Acquired Urinary Tract Infections Caused by ESBL-Producing Enterobacteriaceae –A Case–Control Study in a Low Prevalence Country
- (2013) Arne Søraas et al. PLoS One
- NICE guidance on colistimethate sodium and tobramycin for pseudomonas lung infection in cystic fibrosis
- (2013) Kay Nolan et al. Lancet Respiratory Medicine
- Carbapenem Therapy for Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Escherichia coli or Klebsiella pneumoniae: Implications of Ertapenem Susceptibility
- (2012) Nan-Yao Lee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dosing Nomograms for Attaining Optimum Concentrations of Meropenem by Continuous Infusion in Critically Ill Patients with Severe Gram-Negative Infections: a Pharmacokinetics/Pharmacodynamics-Based Approach
- (2012) Federico Pea et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens
- (2012) Zubair A. Qureshi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ComparativeIn VitroandIn VivoEfficacies of Human Simulated Doses of Ceftazidime and Ceftazidime-Avibactam against Pseudomonas aeruginosa
- (2012) Jared L. Crandon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Decreased Susceptibility to Noncarbapenem Antimicrobials in Extended-Spectrum-β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Isolates in Toronto, Canada
- (2012) Christopher F. Lowe et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Ertapenem for Treatment of Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae
- (2012) Vicki L. Collins et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Cefepime Therapy on Mortality among Patients with Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae and Escherichia coli
- (2012) Teena Chopra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cefoxitin as an Alternative to Carbapenems in a Murine Model of Urinary Tract Infection Due to Escherichia coli Harboring CTX-M-15-Type Extended-Spectrum β-Lactamase
- (2012) Raphaël Lepeule et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Influence of Multidrug Resistance and Appropriate Empirical Therapy on the 30-Day Mortality Rate of Pseudomonas aeruginosa Bacteremia
- (2012) Laura Morata et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study
- (2012) Galo Peralta et al. BMC INFECTIOUS DISEASES
- Transmission Dynamics of Extended-Spectrum β-lactamase–Producing Enterobacteriaceae in the Tertiary Care Hospital and the Household Setting
- (2012) Markus Hilty et al. CLINICAL INFECTIOUS DISEASES
- Cefepime Therapy for Monomicrobial Bacteremia Caused by Cefepime-Susceptible Extended-Spectrum Beta-Lactamase–Producing Enterobacteriaceae: MIC Matters
- (2012) Nan-Yao Lee et al. CLINICAL INFECTIOUS DISEASES
- Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
- (2012) M. Tumbarello et al. CLINICAL INFECTIOUS DISEASES
- High-Dose, Extended-Interval Colistin Administration in Critically Ill Patients: Is This the Right Dosing Strategy? A Preliminary Study
- (2012) L. Dalfino et al. CLINICAL INFECTIOUS DISEASES
- Extended-Spectrum β-Lactamase–Producing Escherichia coli From Retail Chicken Meat and Humans: Comparison of Strains, Plasmids, Resistance Genes, and Virulence Factors
- (2012) Jan A. J. W. Kluytmans et al. CLINICAL INFECTIOUS DISEASES
- Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
- (2012) R. Cantón et al. CLINICAL MICROBIOLOGY AND INFECTION
- Efficacy and safety of ceftazidime–avibactam versus imipenem–cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study
- (2012) José A. Vazquez et al. CURRENT MEDICAL RESEARCH AND OPINION
- Prolonged carriage of resistant E. coli by returned travellers: clonality, risk factors and bacterial characteristics
- (2012) B. A. Rogers et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009–2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)
- (2012) Po-Liang Lu et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Mecillinam/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum -lactamase-producing Escherichia coli
- (2012) N. Lampri et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart--Then Focus
- (2012) D. Ashiru-Oredope et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Increasing incidence of Escherichia coli bacteraemia is driven by an increase in antibiotic-resistant isolates: electronic database study in Oxfordshire 1999-2011
- (2012) I. Schlackow et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Prevalence of acquired fosfomycin resistance among extended-spectrum -lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3
- (2012) S.-Y. Lee et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- High community faecal carriage rates of CTX-M ESBL-producing Escherichia coli in a specific population group in Birmingham, UK
- (2012) N. H. Wickramasinghe et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Association of ertapenem and antipseudomonal carbapenem usage and carbapenem resistance in Pseudomonas aeruginosa among 12 hospitals in Queensland, Australia
- (2012) D. A. J. McDougall et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Strategies for identification of carbapenemase-producing Enterobacteriaceae
- (2012) P. Nordmann et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?
- (2012) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Escherichia coli of human and avian origin: detection of clonal groups associated with fluoroquinolone and multidrug resistance in Italy
- (2012) M. Giufre et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Priorities in the prevention and control of multidrug-resistant Enterobacteriaceae in hospitals
- (2012) A.S. Khan et al. JOURNAL OF HOSPITAL INFECTION
- The Use of Intravenous Colistin Among Children in the United States
- (2012) Pranita D. Tamma et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Risk Factors, Molecular Epidemiology and Outcomes of Ertapenem-Resistant, Carbapenem-Susceptible Enterobacteriaceae: A Case-Case-Control Study
- (2012) Jocelyn Teo et al. PLoS One
- Treatment of Klebsiella Pneumoniae Carbapenemase (KPC) infections: a review of published case series and case reports
- (2012) Grace C Lee et al. Annals of Clinical Microbiology and Antimicrobials
- Carbapenem antibiotics for serious infections
- (2012) P. M. Hawkey et al. BMJ-British Medical Journal
- Overexpression of AmpC and Efflux Pumps in Pseudomonas aeruginosa Isolates from Bloodstream Infections: Prevalence and Impact on Resistance in a Spanish Multicenter Study
- (2011) Gabriel Cabot et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Identifying Patients Harboring Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae on Hospital Admission: Derivation and Validation of a Scoring System
- (2011) Mario Tumbarello et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of Ceftazidime-NXL104 against 396 Strains of β-Lactamase-Producing Anaerobes
- (2011) Diane M. Citron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
- (2011) S. M. Garonzik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cranberries vs Antibiotics to Prevent Urinary Tract Infections
- (2011) Mariëlle A. J. Beerepoot ARCHIVES OF INTERNAL MEDICINE
- The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary healthcare settings
- (2011) Mamoon A. Aldeyab et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- -Lactam/ -Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum -Lactamase-Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts
- (2011) J. Rodriguez-Bano et al. CLINICAL INFECTIOUS DISEASES
- Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention
- (2011) N. Gupta et al. CLINICAL INFECTIOUS DISEASES
- Can We Really Use ss-Lactam/ss-Lactam Inhibitor Combinations for the Treatment of Infections Caused by Extended-Spectrum ss-Lactamase-Producing Bacteria?
- (2011) F. Perez et al. CLINICAL INFECTIOUS DISEASES
- Containment of a Country-wide Outbreak of Carbapenem-Resistant Klebsiella pneumoniae in Israeli Hospitals via a Nationally Implemented Intervention
- (2011) M. J. Schwaber et al. CLINICAL INFECTIOUS DISEASES
- Forgotten Antibiotics: An Inventory in Europe, the United States, Canada, and Australia
- (2011) Céline Pulcini et al. CLINICAL INFECTIOUS DISEASES
- Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains
- (2011) M.A. Leverstein-van Hall et al. CLINICAL MICROBIOLOGY AND INFECTION
- Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment
- (2011) O. Zarkotou et al. CLINICAL MICROBIOLOGY AND INFECTION
- A Multifaceted Intervention Strategy for Eradication of a Hospital-Wide Outbreak Caused by Carbapenem-Resistant Klebsiella pneumoniae in Southern Israel
- (2011) Abraham Borer et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Strategies to overcome extended-spectrum β-lactamases (ESBLs) and AmpC β-lactamases in shigellae
- (2011) David M. Livermore et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline
- (2011) David M. Livermore et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited
- (2011) Gunnar Kahlmeter et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Imipenem: a potent inducer of multidrug resistance in Acinetobacter baumannii
- (2011) Han-Yueh Kuo et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Carbapenem stewardship: does ertapenem affect Pseudomonas susceptibility to other carbapenems? A review of the evidence
- (2011) David P. Nicolau et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Ethical dilemmas in antibiotic treatment
- (2011) L. Leibovici et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens
- (2011) D. E. Karageorgopoulos et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Temocillin use in England: clinical and microbiological efficacies in infections caused by extended-spectrum and/or derepressed AmpC β-lactamase-producing Enterobacteriaceae
- (2011) Indran Balakrishnan et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Impact of antimicrobial stewardship in critical care: a systematic review
- (2011) R. Kaki et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain
- (2011) J. Blanco et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Whole-genome comparison of two Acinetobacter baumannii isolates from a single patient, where resistance developed during tigecycline therapy
- (2011) Michael Hornsey et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Characterization of plasmids encoding extended-spectrum -lactamases and their addiction systems circulating among Escherichia coli clinical isolates in the UK
- (2011) M. Doumith et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comparison of disc diffusion, Etest and agar dilution for susceptibility testing of colistin against Enterobacteriaceae
- (2011) S.M. Maalej et al. LETTERS IN APPLIED MICROBIOLOGY
- Characteristics ofEscherichia colicausing persistence or relapse of urinary tract infections: Phylogenetic groups, virulence factors and biofilm formation
- (2011) Karen Ejrnæs et al. Virulence
- Activities of NXL104 Combinations with Ceftazidime and Aztreonam against Carbapenemase-ProducingEnterobacteriaceae
- (2010) David M. Livermore et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Foreign Travel Is a Major Risk Factor for Colonization with Escherichia coli Producing CTX-M-Type Extended-Spectrum -Lactamases: a Prospective Study with Swedish Volunteers
- (2010) T. Tangden et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin Dosing and Nephrotoxicity in a Large Community Teaching Hospital
- (2010) C. A. DeRyke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Recent Emergence of Clonal Group O25b:K1:H4-B2-ST131 ibeA Strains among Escherichia coli Poultry Isolates, Including CTX-M-9-Producing Strains, and Comparison with Clinical Human Isolates
- (2010) A. Mora et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Validating the prediction of lower urinary tract infection in primary care: sensitivity and specificity of urinary dipsticks and clinical scores in women
- (2010) Paul Little et al. BRITISH JOURNAL OF GENERAL PRACTICE
- AGREE II: advancing guideline development, reporting and evaluation in health care
- (2010) M. C. Brouwers et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Aerosolized plus Intravenous Colistin versus Intravenous Colistin Alone for the Treatment of Ventilator‐Associated Pneumonia: A Matched Case‐Control Study
- (2010) Diamantis P. Kofteridis et al. CLINICAL INFECTIOUS DISEASES
- Multiresistant Gram-negative infections: a global perspective
- (2010) Jennifer Ho et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia
- (2010) Antonio T. Freire et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- In vitro activity of tigecycline and comparators on Acinetobacter spp. isolates collected from patients with bacteremia and MIC change during the Tigecycline Evaluation and Surveillance Trial, 2004 to 2008
- (2010) Yun F. (Wayne) Wang et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Aminoglycoside modifying enzymes
- (2010) Maria S. Ramirez et al. DRUG RESISTANCE UPDATES
- Ertapenem-Resistant Enterobacteriaceae Risk Factors for Acquisition and Outcomes
- (2010) E. P. Hyle et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Adverse events associated with intravenous fosfomycin
- (2010) Amélie Florent et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Tigecycline for severe infections: the gap between the warning and the necessity
- (2010) D. Curcio JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Trends in production of extended-spectrum -lactamases among Enterobacteriaceae of clinical interest: results of a nationwide survey in Belgian hospitals
- (2010) H. Rodriguez-Villalobos et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Improved susceptibility of Gram-negative bacteria in an intensive care unit following implementation of a computerized antibiotic decision support system
- (2010) M. K. Yong et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates
- (2010) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Parallel increase in community use of fosfomycin and resistance to fosfomycin in extended-spectrum -lactamase (ESBL)-producing Escherichia coli
- (2010) J. Oteo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The impact of polymyxin B dosage on in-hospital mortality of patients treated with this antibiotic
- (2010) L. S. Elias et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Regional survey of CTX-M-type extended-spectrum -lactamases among Enterobacteriaceae reveals marked heterogeneity in the distribution of the ST131 clone
- (2010) L. Xu et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Polymyxin B versus other antimicrobials for the treatment of Pseudomonas aeruginosa bacteraemia
- (2010) C. H. Kvitko et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
- (2010) Karthikeyan K Kumarasamy et al. LANCET INFECTIOUS DISEASES
- Infection Reduction Strategies Including Antibiotic Stewardship Protocols in Surgical and Trauma Intensive Care Units Are Associated with Reduced Resistant Gram-Negative Healthcare-Associated Infections
- (2010) Marcus J. Dortch et al. Surgical Infections
- Prospective Observational Study of the Impact of VIM-1 Metallo- -Lactamase on the Outcome of Patients with Klebsiella pneumoniae Bloodstream Infections
- (2009) G. L. Daikos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of Temocillin against KPC-Producing Klebsiella pneumoniae and Escherichia coli
- (2009) J. M. Adams-Haduch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Introduction of Ertapenem into a Hospital Formulary: Effect on Antimicrobial Usage and Improved In Vitro Susceptibility of Pseudomonas aeruginosa
- (2009) E. J. C. Goldstein et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular Characteristics of Extended-Spectrum- -Lactamase-Producing Escherichia coli Isolates Causing Bacteremia in the Calgary Health Region from 2000 to 2007: Emergence of Clone ST131 as a Cause of Community-Acquired Infections
- (2009) J. D. D. Pitout et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa
- (2009) J.-M. Rodriguez-Martinez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Multinational Survey of Risk Factors for Infection with Extended‐Spectrum β‐Lactamase–Producing Enterobacteriaceae in Nonhospitalized Patients
- (2009) Ronen Ben‐Ami et al. CLINICAL INFECTIOUS DISEASES
- Community‐Onset Bacteremia Due to Extended‐Spectrum β‐Lactamase–ProducingEscherichia coli:Risk Factors and Prognosis
- (2009) Jesús Rodríguez‐Baño et al. CLINICAL INFECTIOUS DISEASES
- Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study
- (2009) I.P. Korbila et al. CLINICAL MICROBIOLOGY AND INFECTION
- Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation
- (2009) A. Michalopoulos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit*
- (2009) Andrew F. Shorr CRITICAL CARE MEDICINE
- Intervention with educational outreach at large scale to reduce antibiotics for respiratory tract infections: a controlled before and after study
- (2009) H. Smeets et al. FAMILY PRACTICE
- Clinical characteristics and risk factors of colistin-induced nephrotoxicity
- (2009) Jieun Kim et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections
- (2009) Gian Carlo Schito et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Mecillinam: a low-risk antimicrobial agent for induction of Clostridium difficile infection in an in vitro human gut model
- (2009) S. D. Baines et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of mecillinam against Escherichia coli resistant to third-generation cephalosporins
- (2009) M. Wootton et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin
- (2009) J. Oteo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Nursing homes as a reservoir of extended-spectrum -lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli
- (2009) P. J. Rooney et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline
- (2009) N. C. Gordon et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Evaluation of Phenotypic Tests for Detection of Metallo- -Lactamase-Producing Pseudomonas aeruginosa Strains in China
- (2009) T.-t. Qu et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Acinetobacter: an old friend, but a new enemy
- (2009) K.J. Towner JOURNAL OF HOSPITAL INFECTION
- Community Infections Caused by Extended-Spectrum β-Lactamase–Producing Escherichia coli
- (2008) Jesús Rodríguez-Baño et al. ARCHIVES OF INTERNAL MEDICINE
- Outcomes of Bacteremia due to Pseudomonas aeruginosa with Reduced Susceptibility to Piperacillin-Tazobactam: Implications on the Appropriateness of the Resistance Breakpoint
- (2008) V. H. Tam et al. CLINICAL INFECTIOUS DISEASES
- Risk ofClostridium difficileInfection after Perioperative Antibacterial Prophylaxis before and during an Outbreak of Infection due to a Hypervirulent Strain
- (2008) Alex Carignan et al. CLINICAL INFECTIOUS DISEASES
- Fosfomycin: Use Beyond Urinary Tract and Gastrointestinal Infections
- (2008) Matthew E. Falagas et al. CLINICAL INFECTIOUS DISEASES
- Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia
- (2008) Cristina Tanaseanu et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies
- (2008) Gopi Patel et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies
- (2008) Theodoros Kelesidis et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.
- (2008) M. S. Oliveira et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Faecal carriage of extended-spectrum -lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology
- (2008) J. Rodriguez-Bano et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence
- (2008) D. E. Karageorgopoulos et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Prevalence and distribution of plasmid-mediated quinolone resistance genes in clinical isolates of Escherichia coli lacking extended-spectrum -lactamases
- (2008) G. Ll. Jones et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- European Emergence of Ciprofloxacin-Resistant Escherichia coli Clonal Groups O25:H4-ST 131 and O15:K52:H1 Causing Community-Acquired Uncomplicated Cystitis
- (2008) S. Cagnacci et al. JOURNAL OF CLINICAL MICROBIOLOGY
- High Rate of Intestinal Colonization with Extended-Spectrum- -Lactamase-Producing Organisms in Household Contacts of Infected Community Patients
- (2008) A. Valverde et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Temocillin in cystic fibrosis: A retrospective pilot study
- (2008) Lisa Kent et al. Journal of Cystic Fibrosis
- Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia
- (2008) Alex P. Betrosian et al. JOURNAL OF INFECTION
- Current control and treatment of multidrug-resistant Acinetobacter baumannii infections
- (2008) Drosos E Karageorgopoulos et al. LANCET INFECTIOUS DISEASES
- Mechanism of action of and resistance to quinolones
- (2008) Anna Fàbrega et al. Microbial Biotechnology
- Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005 – 2006
- (2008) David C Bean et al. Annals of Clinical Microbiology and Antimicrobials
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now